Stelara is a medication that is used to treat Crohn's Disease. It contains the active ingredient ustekinumab, which is a biologic medicine. Stelara is administered either through intravenous infusion or subcutaneous injection, depending on the dose and frequency of treatment.
Stelara was approved by the FDA in 2016 for the treatment of moderate to severe Crohn's Disease in adult patients. It is also approved for the treatment of psoriasis and psoriatic arthritis in adult patients.
Clinical studies have shown that treatment with Stelara can result in significant benefits for patients with Crohn's Disease. It has been shown to induce remission in patients who have not responded to other treatments, and also to maintain remission over time. However, like all medications, Stelara may not be suitable for everyone and can cause side effects.
Stelara is available with cost support options for patients to make it more affordable. Janssen CarePath Savings Program is one of the programs that may make paying for Stelara more affordable.
If you are considering Stelara for the treatment of Crohn's Disease , it is important to talk with your doctor to discuss the benefits and risks of this medication, as well as any other treatment options that may be appropriate for you.
Stelara is a company that specializes in developing treatments for Crohn's Disease, a type of inflammatory bowel disease that affects millions of people worldwide.Crohn's Disease is a chronic conditio...